Omega 3 squid oil processor gets Australian approval

By Hank Schultz

- Last updated on GMT

Related tags: Omega-3 fatty acid

Omega 3 squid oil processor gets Australian approval
Pharma Marine, a Norwegian company sourcing omega 3 oils from squid, has announced approval of its Calamarine product by Australia’s Therapeutic Goods Administration.

Sales of the ingredient are expected to being in the country in the third quarter of 2013, according to a statement by the company. The approval came as a result of an 18-month process in conjunction with Pharma Marine’s Australian distributor, Pathway International.

“There is enormous potential for Calamarine to establish a significant position in the Australian market due to its unique value proposition with respect to sustainability and high DHA omega-3 fatty acid profile” ​said Wayne Coote, managing director of Pathway. 

Pharma Marine sources its squid from fisheries in several locations around the world and touts its sustainability profile.  The oil is derived from the offcuts of food grade calamari, and the fishery operations are certified by the Friends of the Sea organization.   

Related topics: Markets, Supplements

Related news

Related product

Follow us

Products

View more

Webinars

Food & Beverage Trailblazers

F&B Trailblazers Podcast